Assessment of Early Pregnancy MAB Completion

Launched by UNIVERSITY OF WASHINGTON · Mar 17, 2025

Keywords

ClinConnect Summary

This clinical trial is looking to find out if a urine pregnancy test can show whether a medication abortion has been successful just two weeks after the procedure, instead of the usual four weeks. The study will also track how the symptoms of early pregnancy change during this time. Women who are early in their pregnancy (up to 42 days) and have chosen to have a medication abortion may be eligible to participate. They will need to be comfortable with receiving text messages and using the internet, and they should be able to read and understand English.

If you decide to join the study, you will take a pregnancy test every week for four weeks and fill out a questionnaire each week about how you are feeling and any pregnancy symptoms you may have. It's important to note that the trial is not yet recruiting participants, so there will be no immediate action required. This study aims to improve our understanding of medication abortions and how quickly we can confirm their success, while also monitoring any changes in pregnancy symptoms.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Pregnant person with early pregnancy ≤42 days
• • Eligible and consented to a medication abortion
• • Have access to receiving text messages and the internet
• • Able to read and understand English
• Exclusion Criteria:
• • - Privacy or safety concerns about filling out the surveys